Investissor login
Back to publications
Companies

Prevost Laboratory Concept optimises its financing structure

March 2022

Prevost Laboratory

Less than two years after Abenex Croissance became its majority shareholder, Prevost Laboratory Concept, a company specialised in the conception and the manufacturing of cosmetics and dietary supplements, has completed a refinancing. 

“This operation intervenes in a context of the business’ outperformance, generating financial results above initial forecasts. The company is led by Marc-Henry Lussigny and his team and has become a leading player in the cosmetics market” adds Paul Bertrand, Partner at Abenex.

The company has recorded a growth rate close to 25% over 2021, while production capacity allows it to meet its development plan’s requirements going forward.

Thanks to its refinancing, the company maintains its ability to pursue potential future external growth acquisitions.

This operation was carried out with the support of “Arkea Banque Entreprises et Institutionnels” - which had already provided financing for the 2020 transaction - and the Crédit Agricole Ille-et-Vilaine.

Arkea Capital remains a shareholder alongside Abenex and the Management.

Share
Abenex Croissance becomes a shareholder of ISCG Paris alongside its management team and Société Général Capital Partenaires
Previous publication

Abenex Croissance becomes a shareholder of ISCG Paris alongside its management team and Société Général Capital Partenaires

Next publication

Angèle France joins Abenex as Associate in the Small Cap team

Angèle France joins Abenex as Associate in the Small Cap team
Previous Abenex Croissance becomes a shareholder of ISCG Paris alongside its management team and Société Général Capital Partenaires
Next Angèle France joins Abenex as Associate in the Small Cap team
Navigate between publications